Andrea Suhner Grotzfeld

Andrea Suhner Grotzfeld, PhD, serves as Vice President of Clinical Development at Tenpoint Therapeutics Ltd since September 2022, focusing on regenerative cell therapies for ocular diseases. Prior to this role, Andrea held multiple positions at Novartis from 2006 to 2022, culminating as Senior Clinical Development Director for ocular gene therapies and previously managing clinical aspects of retinal diseases and glaucoma. Earlier experiences include Clinical Affairs Manager at Biosite, Senior Research Associate at The Scripps Research Institute, and Postdoctoral Fellow at Weill Cornell Medical College. Andrea earned a PhD in Pharmaceutical Sciences from ETH Zürich in 1998.